Seven Centres of Excellence Set Up Under PRIP Scheme
ECONOMY & POLICY

Seven Centres of Excellence Set Up Under PRIP Scheme

The Department of Pharmaceuticals has established seven Centres of Excellence (CoEs), one at each of the seven National Institutes of Pharmaceutical Education and Research (NIPERs), under Component A of the Promotion of Research and Innovation in MedTech Sector (PRIP) scheme. A total amount of Rs 1,834.6 million (mn) has been released for setting up these centres up to 31 January 2026. The centres are intended to strengthen institutional capacity and support translational research in the MedTech sector. They will facilitate partnerships and resource sharing among NIPERs and industry partners to advance applied research.

A total of 710 research projects were received from industry, start-ups and MSMEs by the closing date of 19 November 2025, including projects in priority areas that are eligible for higher financial support under the PRIP scheme. Approval for financial assistance under the scheme, including full funding assistance and higher funding assistance to eligible projects, is provided after a multi-stage appraisal process as prescribed under the scheme guidelines.

The information was supplied by the Union Minister of State for Chemicals and Fertilizers, Anupriya Patel, in a written reply to the Rajya Sabha. The initiative is designed to promote collaboration between academic institutions and the private sector, facilitate technology transfer and nurture start-ups that can translate research into marketable medical devices and solutions. The ministerial reply set out the number of projects received and the financial assistance framework under the scheme.

The scheme is intended to ensure that priority projects receive necessary support through prescribed appraisal and funding mechanisms and to strengthen the pipeline from laboratory research to clinical and commercial application. Officials expect the Centres of Excellence to offer specialised facilities, training and industry engagement that should accelerate the development and deployment of MedTech innovations across the country. The department will continue to monitor progress and disbursement of funds as projects proceed through appraisal stages.

The Department of Pharmaceuticals has established seven Centres of Excellence (CoEs), one at each of the seven National Institutes of Pharmaceutical Education and Research (NIPERs), under Component A of the Promotion of Research and Innovation in MedTech Sector (PRIP) scheme. A total amount of Rs 1,834.6 million (mn) has been released for setting up these centres up to 31 January 2026. The centres are intended to strengthen institutional capacity and support translational research in the MedTech sector. They will facilitate partnerships and resource sharing among NIPERs and industry partners to advance applied research. A total of 710 research projects were received from industry, start-ups and MSMEs by the closing date of 19 November 2025, including projects in priority areas that are eligible for higher financial support under the PRIP scheme. Approval for financial assistance under the scheme, including full funding assistance and higher funding assistance to eligible projects, is provided after a multi-stage appraisal process as prescribed under the scheme guidelines. The information was supplied by the Union Minister of State for Chemicals and Fertilizers, Anupriya Patel, in a written reply to the Rajya Sabha. The initiative is designed to promote collaboration between academic institutions and the private sector, facilitate technology transfer and nurture start-ups that can translate research into marketable medical devices and solutions. The ministerial reply set out the number of projects received and the financial assistance framework under the scheme. The scheme is intended to ensure that priority projects receive necessary support through prescribed appraisal and funding mechanisms and to strengthen the pipeline from laboratory research to clinical and commercial application. Officials expect the Centres of Excellence to offer specialised facilities, training and industry engagement that should accelerate the development and deployment of MedTech innovations across the country. The department will continue to monitor progress and disbursement of funds as projects proceed through appraisal stages.

Related Stories

Gold Stories

Next Story
Resources

Schindler named among Forbes’ World’s Best Employers 2026

Schindler has been named among Forbes’ World’s Best Employers 2026, a global ranking recognising companies for their workplace environments.Compiled by Forbes in partnership with Statista, the ranking is based on independent employee feedback, including whether employees would recommend their organisation to friends and family.The company said the recognition reflected its focus on creating a workplace where employees can develop their expertise and build careers. ..

Next Story
Infrastructure Urban

India needs an export-execution mindset: Vishesh Jain

Interview with Vishesh Jain, Founder & CEO, EximpleWhat gaps in India’s global trade ecosystem led you to build Eximple, and what problem did you see businesses struggling with most?Eximple came out of a problem that all three founders had seen from different choke points in the trade ecosystem. India has millions of MSMEs and manufacturers, and many of them can make products that are genuinely competitive on quality. Yet only a small fraction is able to build meaningful international businesses. In our experience, the gap is usually not manufacturing capability; it is the ability to exe..

Next Story
Building Material

Nuvoco reports 13.5% revenue growth in Q2 FY27

Nuvoco Vistas Corp. Ltd. reported consolidated revenue of Rs 27.9 billion for Q2 FY27, up 13.5% year on year. Cement sales volume rose 9% to 4.7 million tonnes (MMT), while EBITDA increased 11% to Rs 4.11 billion.The company said it began its cement operations in 2014 with a 2.3 MMT per annum (MMTPA) operation at Nimbol. It now aims to reach 35 MMTPA of cement capacity by FY28, nearly 15 times its initial capacity. Its portfolio spans cement, ready-mix concrete and modern building materials.On sustainability and cost efficiency, Nuvoco partnered with CleanMax for a 46.4 MW wind-solar hybrid re..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

SPECIAL OFFER
QR Code